A Phase II Open Label Study of SU101 for Patients With Anaplastic Astrocytoma in First Relapse

Trial Profile

A Phase II Open Label Study of SU101 for Patients With Anaplastic Astrocytoma in First Relapse

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2012

At a glance

  • Drugs Leflunomide (Primary)
  • Indications Anaplastic astrocytoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top